MARATTO

article · Plant Signaling & Behavior

Unraveling alfalfa molecular adaptation to salinity and <i>Ascochyta medicaginicola</i> infection: insights from differential physiological traits and proteomics profiling

Abstract

infection. Both varieties exhibited reductions in stem length, leaf relative water content, and chlorophyll content, with a greater decrease in Magna-601. Label-free LC‒MS/MS analysis identified 128 differentially abundant proteins (DAPs) between the two varieties, of which 14, 60, and 70 proteins were differentially regulated under salinity, Pm8 infection, and combined stresses, respectively. Gene Ontology analyses revealed that Gabes-2353 activated photosynthesis, metabolism, redox balance, and immune pathways, while Magna-601 disrupted carbohydrate metabolism. Pm8 infection induced immune pathways in both varieties, with antioxidant and metabolic proteins expressed in Gabes-2353, while protease inhibitors and defense proteins were expressed in Magna-601. Under combined stress, Gabes-2353 upregulated proteins associated with synergistic integration of metabolic and immune pathways. In contrast, Magna-601 activated broad stress-signaling responses but inhibited primary metabolism, aminoacyl-tRNA biosynthesis, and vitamin metabolism. The PPI and KEGG analyses identified 7-O-methyltransferase as a central hub in Gabes-2353, while Magna-601's PPI network focused on starch mobilization, reflecting differential adaptation strategies.

Research topics

  • Plant Stress Responses and Tolerance
  • Plant responses to water stress
  • Plant Gene Expression Analysis

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/15592324.2025.2600835

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.